Chen R - Search Results

1

SRRM4 gene expression correlates with neuroendocrine prostate cancer.

Li Y, Zhang Q, Lovnicki J, Chen R, Fazli L, Wang Y, Gleave M, Huang J, Dong X. Li Y, et al. Among authors: chen r. Prostate. 2019 Jan;79(1):96-104. doi: 10.1002/pros.23715. Epub 2018 Aug 28. Prostate. 2019. PMID: 30155992

2

Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4.

Li Y, Chen R, Bowden M, Mo F, Lin YY, Gleave M, Collins C, Dong X. Li Y, et al. Among authors: chen r. Oncotarget. 2017 Aug 3;8(40):66878-66888. doi: 10.18632/oncotarget.19916. eCollection 2017 Sep 15. Oncotarget. 2017. PMID: 28978002 Free PMC article.

3

Molecular model for neuroendocrine prostate cancer progression.

Chen R, Dong X, Gleave M. Chen R, et al. BJU Int. 2018 Oct;122(4):560-570. doi: 10.1111/bju.14207. Epub 2018 Apr 24. BJU Int. 2018. PMID: 29569310 Review.

4

RNA Splicing of the BHC80 Gene Contributes to Neuroendocrine Prostate Cancer Progression.

Li Y, Xie N, Chen R, Lee AR, Lovnicki J, Morrison EA, Fazli L, Zhang Q, Musselman CA, Wang Y, Huang J, Gleave ME, Collins C, Dong X. Li Y, et al. Among authors: chen r. Eur Urol. 2019 Aug;76(2):157-166. doi: 10.1016/j.eururo.2019.03.011. Epub 2019 Mar 23. Eur Urol. 2019. PMID: 30910347 Free article.

5

Progesterone receptor in the prostate: A potential suppressor for benign prostatic hyperplasia and prostate cancer.

Chen R, Yu Y, Dong X. Chen R, et al. J Steroid Biochem Mol Biol. 2017 Feb;166:91-96. doi: 10.1016/j.jsbmb.2016.04.008. Epub 2016 Apr 25. J Steroid Biochem Mol Biol. 2017. PMID: 27125450 Review.

6

UGT2B17 Expedites Progression of Castration-Resistant Prostate Cancers by Promoting Ligand-Independent AR Signaling.

Li H, Xie N, Chen R, Verreault M, Fazli L, Gleave ME, Barbier O, Dong X. Li H, et al. Among authors: chen r. Cancer Res. 2016 Nov 15;76(22):6701-6711. doi: 10.1158/0008-5472.CAN-16-1518. Epub 2016 Sep 22. Cancer Res. 2016. PMID: 27659047

7

Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells.

Chen R, Li Y, Buttyan R, Dong X. Chen R, et al. Oncotarget. 2017 Jul 19;8(49):84863-84876. doi: 10.18632/oncotarget.19386. eCollection 2017 Oct 17. Oncotarget. 2017. PMID: 29156689 Free PMC article.

8

Correction: Implications of PI3K/AKT inhibition on REST protein stability and neuroendocrine phenotype acquisition in prostate cancer cells.

Chen R, Li Y, Buttyan R, Dong X. Chen R, et al. Oncotarget. 2018 Jul 3;9(51):29842. doi: 10.18632/oncotarget.25759. eCollection 2018 Jul 3. Oncotarget. 2018. PMID: 30038724 Free PMC article.

9

Loss of Nuclear Functions of HOXA10 Is Associated With Testicular Cancer Proliferation.

Chen R, Li H, Li Y, Fazli L, Gleave M, Nappi L, Dong X. Chen R, et al. Front Oncol. 2018 Dec 7;8:594. doi: 10.3389/fonc.2018.00594. eCollection 2018. Front Oncol. 2018. PMID: 30581773 Free PMC article.

10

Understanding aberrant RNA splicing to facilitate cancer diagnosis and therapy.

Dong X, Chen R. Dong X, et al. Among authors: chen r. Oncogene. 2020 Mar;39(11):2231-2242. doi: 10.1038/s41388-019-1138-2. Epub 2019 Dec 9. Oncogene. 2020. PMID: 31819165 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

24,480 results

Search Page

Filters